Browsing: Mortality Risk
Longevity and Mortality Investor’s coverage of bulk purchase annuity transactions. We are a leading source globally for mortality risk analysis, commentary and insights.
For those in the longevity and mortality modelling game, 2025 has provided plenty of activity to keep the actuaries busy. Greg Winterton spoke to James Hadley, Senior Consultant at Barnett Waddingham, to learn more about what is front and centre of the conversation in his world as the year draws to a close.
A convergence of themes has contributed to the growth story of the US life and annuity market of the past few years.
The subject of whether life insurance-linked securities (life ILS) structures should be rated or not is a conversation almost as old as the market itself.
The longevity economy is multi-faceted, with a range of investment opportunities available that can impact longevity in different ways. Greg Winterton spoke to Sergey Jakimov, Founding Partner of venture capital firm LongeVC, to get his views on both the space overall, and how LongeVC sees it, and therefore, approaches it in our latest Q&A.
The most recent mortality monitor from the Continuous Mortality Investigation shows that overall mortality in England and Wales in the third quarter of 2025 was lower than in any other quarter. The previous record low was for the third quarter of 2020, in the aftermath of the first wave of the Covid-19 pandemic.
Longevity and Mortality Investor (LMI) is the new name for Life Risk News. Greg Winterton caught up with Chris Wells, Managing Editor at LMI, to discuss the reasons behind the rebrand, his thoughts on how the longevity and mortality markets have evolved in recent years, and plans for the future.
Athene will reinsure an in-force block of US dollar denominated whole life insurance policies and will enter into an agreement with reinsurer Swiss Re to retrocede all mortality risk associated with the block.
HSCM Bermuda Closes Secondaries Fund to Acquire Life Insurance-Linked Securities Portfolio: HS Sawmill LP closes with $110m of capital commitments.
The number of policies sold rose 7% in the second quarter, which is the highest growth rate recorded in LIMRA’s quarterly survey since 1983.
A recent article in The Lancet Public Health suggests that walking 7,000 steps is associated with reductions in the risk of several serious health outcomes.